BlackRock, Inc. 13D and 13G filings for Xeris Biopharma Holdings, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-01-26 4:23 pm Purchase | 2023-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS | BlackRock Inc. BLK | 10,011,391 7.200% | 1,435,178 (+16.73%) | Filing |
| 2023-02-10 09:04 am Purchase | 2022-12-31 | 13G | Xeris Biopharma Holdings, Inc. XERS | BlackRock Inc. BLK | 8,576,213 6.300% | 8,576,213 (New Position) | Filing |